Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > Ventana and Quantum Dot Announce Agreement

September 7th, 2004

Ventana and Quantum Dot Announce Agreement

Abstract:
Ventana Medical Systems, Inc. and Quantum Dot Corporation announced comprehensive licensing and supply agreements relating to QDC's QdotŪ nanocrystal technology for in vitro diagnostic applications in Anatomic Pathology and Cytology.

Story:

Ventana and Quantum Dot Announce Agreement

Tucson, AZ, and Hayward, CA . September 7th, 2004

Ventana Medical Systems, Inc. (Nasdaq: VMSI), and Quantum Dot Corporation (QDC) announced comprehensive licensing and supply agreements relating to QDC's QdotŪ nanocrystal technology for in vitro diagnostic applications in Anatomic Pathology and Cytology. Ventana will also incorporate QDC technology in its research and pharmaceutical discovery platforms. Under the terms of the agreement, QDC will supply Qdot nanocrystals for Ventana's incorporation into next-generation rapid, quantitative, and multiplexed assays for cancer diagnosis and disease management. Financial terms of the agreement were not disclosed.

"As a leading provider of automated diagnostic solutions, Ventana is committed to identifying those technologies that enable us to effectively address the increasing demands placed on the anatomical pathology laboratory in the important role they play in improving patient care," stated Christopher Gleeson, President and Chief Executive Officer of Ventana. "Quantum Dot's expertise and intellectual property provide tools for Ventana to extend our leadership position in tissue-based molecular diagnostics, and we look forward to a very productive partnership."

"The choice of our Qdot nanocrystals for Ventana's expansion into fluorescent in vitro diagnostics continues to validate the value of our technology," commented George Dunbar, QDC's Chief Executive Officer. "Leveraging Ventana's development expertise and worldwide sales and distribution capabilities is an effective way to provide Qdot nanocrystal products to anatomic pathology customers. This is a good model for future field-defined partnerships for our company."

About Ventana Medical Systems, Inc.

Ventana develops, manufactures, and markets instrument/reagent systems that automate slide preparation and staining in clinical histology and drug discovery laboratories worldwide. Ventana's clinical systems are important tools used in the diagnosis and treatment of cancer and infectious diseases. Ventana's drug discovery systems are used to accelerate the discovery of new drug targets and evaluate the safety of new drug compounds.

About Quantum Dot Corporation (www.qdots.com)

Quantum Dot is a privately held bioscience company that has pioneered the development and commercialization of QdotŪ nanocrystals for bio-detection in discovery and clinical applications. QDC's current products include more than 40 life science kits and applications, used by life science discovery laboratories worldwide. QDC will soon be launching its first integrated instrumentation, software, and bio-reagents platform, the Mosaic™ system, for rapid and quantitative multiplexed gene expression analysis. QDC collaborates with leading academic and industrial partners and has over 130 patents and patents-pending.

Any statements made about the Ventana's anticipated success of product development activities and product development are forward-looking statements subject to risks and uncertainties, such as the risks inherent in the development, manufacturing, marketing and sale of medical products, competitive factors, general economic conditions, legal disputes, and government actions as more fully described in Ventana's Annual Report on Form 10-K for the year ended December 31, 2003. Actual results may differ materially from anticipated results.

Ventana Medical Systems Contacts:
Christopher M. Gleeson
President and CEO
(520) 229-3787

Nick Malden
Chief Financial Officer
(520) 229-3857

Quantum Dot Corporation Contacts:
George Dunbar
CEO
(510) 887-8775

Carol Lou
President
(510) 887-8775

Copyright Ventana Medical Systems and Quantum Dot Corporation. Reprinted with permission.

If you have a comment, please us.


Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Nanometrics Announces Upcoming Investor Events August 3rd, 2017

Nanometrics to Participate in the 9th Annual CEO Investor Summit 2017: Accredited investor and publishing research analyst event held concurrently with SEMICON West and Intersolar 2017 in San Francisco June 27th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Nanomedicine

Do titanium dioxide particles from orthopedic implants disrupt bone repair? September 16th, 2017

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Graphene based terahertz absorbers: Printable graphene inks enable ultrafast lasers in the terahertz range September 13th, 2017

Applications for the nanomedTAB are open until September 18th, 2017 September 13th, 2017

Announcements

Solar-to-fuel system recycles CO2 to make ethanol and ethylene: Berkeley Lab advance is first demonstration of efficient, light-powered production of fuel via artificial photosynthesis September 19th, 2017

A new approach to ultrafast light pulses: Unusual fluorescent materials could be used for rapid light-based communications systems September 19th, 2017

New quantum phenomena in graphene superlattices September 18th, 2017

Do titanium dioxide particles from orthopedic implants disrupt bone repair? September 16th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project